Literature DB >> 11668511

International trends and patterns of primary liver cancer.

K A McGlynn1, L Tsao, A W Hsing, S S Devesa, J F Fraumeni.   

Abstract

Primary liver cancer (PLC) is common in many areas of the developing world, but uncommon in most of the developed world. Some evidence suggests, however, that the global pattern of PLC may be changing. To clarify this issue, we examined incidence rates for PLC over the 15-year time period, 1978-92, in selected cancer registries around the world. With some exceptions, developed countries have experienced PLC increases in incidence whereas developing countries have experienced declines. Although the reasons for the trends are not entirely clear, the increased seroprevalence of HCV in the developed world and the elimination of HBV-cofactors in the developing world are likely to have contributed to the patterns. Further progress against PLC may be seen in the developing world once the HBV-vaccinated segment of the population reaches adulthood. Published 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668511     DOI: 10.1002/ijc.1456

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  89 in total

1.  From liver cirrhosis to HCC.

Authors:  Luigi Bolondi; Laura Gramantieri
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

2.  Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma.

Authors:  Upama Liengswangwong; Anant Karalak; Yukio Morishita; Masayuki Noguchi; Thiravud Khuhaprema; Petcharin Srivatanakul; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

3.  Cancer in Canada in 2008.

Authors:  Loraine D Marrett; Prithwish De; Parisa Airia; Dagny Dryer
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

4.  Time trends of incidence of digestive system cancers in changle of China during 1988-2002.

Authors:  Jun Tian; Jian-Shun Chen
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

5.  Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells.

Authors:  You-Cheng Zhang; Xiao-Peng Wang; Ling-Yi Zhang; Ai-Lin Song; Zhi-Min Kou; Xu-Sheng Li
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

6.  HCV-related mortality among male prison inmates in Texas, 1994-2003.

Authors:  Amy J Harzke; Jacques G Baillargeon; Michael F Kelley; Pamela M Diamond; Karen J Goodman; David P Paar
Journal:  Ann Epidemiol       Date:  2009-05-13       Impact factor: 3.797

7.  Diallyl sulfide protects against N-nitrosodiethylamine-induced liver tumorigenesis: role of aldose reductase.

Authors:  Safinaz-S Ibrahim; Noha-N Nassar
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

Review 8.  Chronic hepatitis B in children and adolescents: epidemiology and management.

Authors:  Mona Abdel-Hady; Deirdre Kelly
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

9.  Insulin-like growth factors and liver cancer risk in male smokers.

Authors:  J M Major; R Z Stolzenberg-Solomon; M N Pollak; K Snyder; J Virtamo; D Albanes
Journal:  Br J Cancer       Date:  2010-08-17       Impact factor: 7.640

10.  Sorafenib for the treatment of unresectable hepatocellular carcinoma.

Authors:  Junji Furuse
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.